Alpha Cognition Inc
ACOG
Classement en actions
#20078
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Prix de l'action
$8.66
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$134.50M
Changement (1 jour)
1.88%
Changement (1 an)
72.17%
Pays
US
Échange Alpha Cognition Inc (ACOG)
Catégorie
Healthcare
Nombre d'actions en circulation pour Alpha Cognition Inc (ACOG)
Nombre d'actions en circulation au June 2026: 21.77M
Selon les derniers rapports financiers et le cours de l'action de Alpha Cognition Inc, le nombre actuel d'actions en circulation est de 21.77M. À la fin de December 2022, l'entreprise avait 67.97M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Alpha Cognition Inc (ACOG) de 2018 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 21.77M | -76.92% |
| 2023 | 94.36M | 38.81% |
| 2022 | 67.97M | 27.45% |
| 2021 | 53.33M | 786.67% |
| 2020 | 6.02M | -80.88% |
| 2019 | 31.46M | 2,539.28% |
| 2018 | 1.19M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 1,066.06% |
US
|
|
| 396.00M | 1,718.67% |
US
|
|
| 478.91M | 2,099.46% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 185.59% |
NL
|
